Page 101 - EASL POSTGRADUATE COURSE
P. 101
References
[1] Bellentani S, Saccoccio G, Costa G, et al. Drinking habits as cofactors of risk for alcohol induced
liver damage. The Dionysos Study Group. Gut 1997;41:845-850.
[2] Ratziu V, Bellentani S, Cortez-Pinto H, et al. A position statement on NAFLD/NASH based on
the EASL 2009 special conference. J Hepatol 2010;53:372-384.
[3] Moriya A, Iwasaki Y, Ohguchi S, et al. Roles of alcohol consumption in fatty liver: a longitudinal
study. J Hepatol 2014; doi: 10.1016/j.jhep.2014.11.025.
[4] Sinn DH, Gwak GY, Cho J, et al. Modest alcohol consumption and carotid plaques or carotid
artery stenosis in men with non-alcoholic fatty liver disease. Atherosclerosis 2014;234:270-275.
[5] Loomba R,Yang HI, Su J, et al. Synergism between obesity and alcohol in increasing the risk of
hepatocellular carcinoma: a prospective cohort study. Am J Epidemiol 2013;177:333-342.
[6] Nascimbeni F, Pais R, Bellentani S, et al. From NAFLD in clinical practice to answers from
guidelines. J Hepatol 2013;59:859-871.
[7] Koppes LL, Dekker JM, Hendriks HF, et al. Moderate alcohol consumption lowers the risk of
type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care 2005;28:719-
725.
[8] Hodge AM, English DR, O’Dea K, et al. Alcohol intake, consumption pattern and beverage type,
and the risk of Type 2 diabetes. Diabet Med 2006;23:690-697.
[9] Shi L, Shu XO, Li H, et al. Physical activity, smoking, and alcohol consumption in association
with incidence of type 2 diabetes among middle-aged and elderly Chinese men. PLoS One
2013;8:e77919.
[10] Beulens JW, van der Schouw YT, Bergmann MM, et al. Alcohol consumption and risk of type
2 diabetes in European men and women: influence of beverage type and body size The EPIC-
InterAct study. J Intern Med 2012;272:358-370.
The International Liver Congress™ 2015 • Vienna, Austria • April 22–23, 2015 101
[1] Bellentani S, Saccoccio G, Costa G, et al. Drinking habits as cofactors of risk for alcohol induced
liver damage. The Dionysos Study Group. Gut 1997;41:845-850.
[2] Ratziu V, Bellentani S, Cortez-Pinto H, et al. A position statement on NAFLD/NASH based on
the EASL 2009 special conference. J Hepatol 2010;53:372-384.
[3] Moriya A, Iwasaki Y, Ohguchi S, et al. Roles of alcohol consumption in fatty liver: a longitudinal
study. J Hepatol 2014; doi: 10.1016/j.jhep.2014.11.025.
[4] Sinn DH, Gwak GY, Cho J, et al. Modest alcohol consumption and carotid plaques or carotid
artery stenosis in men with non-alcoholic fatty liver disease. Atherosclerosis 2014;234:270-275.
[5] Loomba R,Yang HI, Su J, et al. Synergism between obesity and alcohol in increasing the risk of
hepatocellular carcinoma: a prospective cohort study. Am J Epidemiol 2013;177:333-342.
[6] Nascimbeni F, Pais R, Bellentani S, et al. From NAFLD in clinical practice to answers from
guidelines. J Hepatol 2013;59:859-871.
[7] Koppes LL, Dekker JM, Hendriks HF, et al. Moderate alcohol consumption lowers the risk of
type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care 2005;28:719-
725.
[8] Hodge AM, English DR, O’Dea K, et al. Alcohol intake, consumption pattern and beverage type,
and the risk of Type 2 diabetes. Diabet Med 2006;23:690-697.
[9] Shi L, Shu XO, Li H, et al. Physical activity, smoking, and alcohol consumption in association
with incidence of type 2 diabetes among middle-aged and elderly Chinese men. PLoS One
2013;8:e77919.
[10] Beulens JW, van der Schouw YT, Bergmann MM, et al. Alcohol consumption and risk of type
2 diabetes in European men and women: influence of beverage type and body size The EPIC-
InterAct study. J Intern Med 2012;272:358-370.
The International Liver Congress™ 2015 • Vienna, Austria • April 22–23, 2015 101
